IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrington, L.
Right arrow Articles by Boulton, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrington, L.
Right arrow Articles by Boulton, M.
(Investigative Ophthalmology and Visual Science. 2000;41:1210-1216.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

IL-10 and Antibodies to TGF-ß2 and PDGF Inhibit RPE-Mediated Retinal Contraction

Louise Carrington1, David McLeod2 and Mike Boulton1

1 From the Cell and Molecular Biology Unit, Department of Optometry and Vision Sciences, University of Cardiff, United Kingdom; and the 2 Department of Ophthalmology, Manchester Royal Eye Hospital, United Kingdom.

PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell–mediated contraction of the retina.

METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-ß1, TGF-ß2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-ß2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area.

RESULTS. RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-ß2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-ß2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-ß2 on RPE-mediated contraction of the retina (P < 0.01).

CONCLUSIONS. These findings confirm a role for both PDGF and TGF-ß2 in RPE cell–mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-ß2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.




This article has been cited by other articles:


Home page
IOVSHome page
H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas
A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2335 - 2342.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. Saika, O. Yamanaka, I. Nishikawa-Ishida, A. Kitano, K. C. Flanders, Y. Okada, Y. Ohnishi, Y. Nakajima, and K. Ikeda
Effect of Smad7 Gene Overexpression on Transforming Growth Factor beta-Induced Retinal Pigment Fibrosis in a Proliferative Vitreoretinopathy Mouse Model
Arch Ophthalmol, May 1, 2007; 125(5): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. M. Carrington, J. Albon, I. Anderson, C. Kamma, and M. Boulton
Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-{beta} Isoforms and Their Inhibitors
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1886 - 1894.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. H. Eibl, D. Kook, S. Priglinger, C. Haritoglou, A. Yu, A. Kampik, and U. Welge-Lussen
Inhibition of Human Retinal Pigment Epithelial Cell Attachment, Spreading, and Migration by Alkylphosphocholines
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 364 - 370.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi
The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. H. Eibl, B. Banas, C.-L. Schoenfeld, C. A. May, A. S. Neubauer, S. Priglinger, A. Kampik, and U. Welge-Lussen
Alkylphosphocholines Inhibit Proliferation of Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3556 - 3561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology